Joint IOGP-IPIECA position on COVID-19 vaccines

Published on 26 November 2021

The IOGP-IPIECA joint Health Committee has followed the development, rollout, and real-world efficacy of COVID-19 vaccines since they became available in late 2020.

This document aims to help companies understand vaccine efficacy and provides guidance for company policy development aimed at achieving high rates of vaccination amongst staff.